Majesty Life Coach

How Enzymes Flock Together to Produce Liver Fat

BusinessManasi Praharaj20 Nov 2026

DALLAS, Nov 20, 2026:  Enzymes necessary to produce fat in the liver come from far-flung cellular locations to form a unit, a study led by UT Southwestern Medical Center researchers suggests. The findings, published in Molecular Cell, could lead to new ways to fight fatty liver disease, a condition known clinically as metabolic dysfunction-associated steatotic liver disease (MASLD) that affects over a third of U.S. adults.

“In MASLD, rates of fat synthesis are too high, resulting in excessive fat accumulation in the liver. Reducing fat synthesis by disrupting the formation of this enzyme complex may provide a new therapeutic opportunity to treat fatty liver disease,” said study leader Jay Horton, M.D., Director of the Center for Human Nutrition and Professor of Internal Medicine and Molecular Genetics at UT Southwestern.

Spurred by an epidemic of excess body weight and obesity worldwide, MASLD is a leading cause of cirrhosis and liver cancer. Over the past few decades, research at UTSW and elsewhere has identified a cascade of enzymes that produce fat in liver cells through a stepwise process. However, Dr. Horton said, because these enzymes are based in different cellular locations, how they work together to generate fat was a mystery.

To shed light on this process, he and colleagues in the Horton Lab used a method called immunoprecipitation, which uses antibodies to pull molecules of interest out of the cellular milieu. These molecules bring along others they interact with, giving researchers an idea of which molecules are together in cells at any given point.

The researchers used this technique to target an enzyme called ACC1 that’s central to liver fat synthesis. Although ACC1 is typically based in the liquid portion of cells called the cytosol, immunoprecipitation pulled out other enzymes in the fat-producing cascade based in organelles including mitochondria and the endoplasmic reticulum. A different method called immunofluorescence – which makes antibody-tagged molecules glow – showed that these enzymes were often grouped together around lipid droplets, which act as fat storage depots in cells. The researchers saw significantly more of these enzyme complexes in liver cells from animal models fed diets that encouraged fat production or were genetically predisposed to MASLD compared with those that ate standard lab chow.

These enzymes might be found together because they form a metabolon – a complex of enzymes and other related proteins that perform reactions in sequence as part of the same molecular cascade. Being physically close facilitates the next enzyme in each step of the sequence to act on the product of the previous one. The metabolon concept was popularized in the early 1970s by Paul Srere, Ph.D., a biochemist at UTSW, who coined the term in a lecture in Hungary in 1985.

How these enzymes come together in liver cells is still unclear, Dr. Horton said. That will be a topic for future research in the Horton Lab. Learning more about this process could reveal ways to interfere with it, he added, offering a new avenue for treating MASLD.

Dr. Horton also serves as Director of the Nutrition & Obesity Research Center at UTSW and is a member of the Harold C. Simmons Comprehensive Cancer Center.

Other UTSW researchers who contributed to this study are co-first authors Xiaotong Zhu, Ph.D., Assistant Professor, and Chai-Wan Kim, Ph.D., Associate Professor, both in the Center for Human Nutrition and of Internal Medicine; Shawn C. Burgess, Ph.D., Professor in the Center for Human Nutrition and of Pharmacology; and Xiaorong Fu, Ph.D., Associate Professor in the Center for Human Nutrition and of Internal Medicine.

Dr. Horton holds the Distinguished University Chair in Human Nutrition, the Center for Human Nutrition Director’s Endowed Chair, and the Scott Grundy Director’s Chair.